Soc. Generale Call 0.82 USDCHF 21.../ DE000SW1D9W1 /
27/05/2024 9:58:25 | Diferencia+0.030 | Bid10:13:28 | Ask10:13:28 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
9.300EUR | +0.32% | 9.310 Volumen de oferta: 30,000 |
9.330 Tamaño/ Volumen/ Formato de Ask: 30,000 |
CROSSRATE USD/CHF | 0.82 CHF | 21/06/2024 | Call |
GlobeNewswire
10:00
Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire
10:00
TDOC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Teladoc Health, Inc. Investors...
GlobeNewswire
10:00
GDRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that GoodRx Holdings, Inc. Investor...
GlobeNewswire
10:00
SHCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sharecare Inc. Investors with ...
GlobeNewswire
10:00
VFS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that VinFast Auto Ltd. (f/k/a Black ...
GlobeNewswire
10:00
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Investors with Sub...
GlobeNewswire
10:00
INTC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Intel Corporation Investors wi...
GlobeNewswire
7:00
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible ...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página